Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-08
1995-12-19
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142375, 514456, 514469, 514510, 514539, 514546, 514562, 514567, 514569, 514618, 514620, 514677, 514681, 514682, 514700, 514717, 514719, 514721, 514732, 544165, 544173, 544174, 546205, 549 23, 549398, 560 10, 560 46, 560 56, 560 66, 560 67, 562427, 562453, 562466, 562475, 564162, 564165, 564171, 564172, 568 44, 568 49, 568326, 568327, 568441, 568632, 568633, 568732, 424401, 424428, A61K 31445, A61K 3119, C07C 6511, C07D21132
Patent
active
054768608
ABSTRACT:
Diaromatic compounds, characterized in that they correspond to the following general formula: ##STR1## in which: R.sub.1 is --CH.sub.3, --CH.sub.2 OH, --COR.sub.8 or --CH.sub.2 OCOR.sub.9, R.sub.8 is H, OH, --OR.sub.10, --N(rr') or alkyl, R.sub.10 is alkyl, alkenyl, aryl or aralkyl, r and r' being H, alkyl, aryl, aralkyl, etc., r and r' together form a heterocycle, R.sub.9 is alkyl, alkenyl or a sugar residue, R.sub.2 and R.sub.3 are --OR.sub.11 or --OCOR.sub.11, R.sub.11 is H, alkyl, fluoroalkyl, aryl or aralkyl, R.sub.3 in addition being H, R.sub.4 is H, OH, alkyl, alkoxy, F, Cl or --CF.sub.3, R.sub.5 and R.sub.7 are H, OH, alkoxy, .alpha.-substituted alkyl or .alpha.,.alpha.'-disubstituted alkyl, etc., R.sub.6 is H, OH, alkyl, alkoxy, cycloalkyl, etc., R.sub.5 and R.sub.7 cannot simultaneously be OH or alkoxy and R.sub.4, R.sub.5, R.sub.6 and R.sub.7 cannot simultaneously be H, R.sub.5 and R.sub.6 or R.sub.6 and R.sub. 7 can form, with the aromatic ring, a ring with 5 or 6 members, X is chosen from amongst:
REFERENCES:
patent: 4937371 (1990-06-01), Carson et al.
Carson et al, Chemical Abstracts, vol. 111 (1989) 153363.
CA Previews, 94:553188 (1994).
S. Strickland et al., "Structure-Activity Relationships of a New Series of etinoidal Benzoic Acid Derivatives as Measured by Induction of Differentiation of Murine F9 Teratocarcinoma Cells and Human HL-60 Promyelocytic Leukemia Cells", Cancer Research, 43, pp. 5268-5272, Nov. 1983.
A. K. Verma et al., "Inhibition of 12-O-Tetradecanoylphorbol-13-acetate-induced Ornithine Decarboxylase Activity in Mouse Epidermis by Vitamin A Analogs (Retinoids)", Cancer Research, 38, pp. 793-801, Mar. 1978.
M. M. Goodman et al., "Human Keratinocyte X HeLa Hydrids for Detection of Keratinocyte Differentiation-Specific Antigens", Models Dermatol., 1989, vol. 4, pp. 1-4.
J. M. Geiger et al., "Rat Vaginal Epithelium Assay for Screening Retinoids", Pharmacol Skin., 1989, vol. 3, pp. 141-143.
Centre International de Recherches Dermatologiques (CIRD Galderm
Raymond Richard L.
LandOfFree
Diaromatic compounds derived from a salicylic unit and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diaromatic compounds derived from a salicylic unit and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaromatic compounds derived from a salicylic unit and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-992267